Collegium Pharmaceutical Announces Pricing of Its Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Collegium Pharmaceutical (COLL) IPO Opens Flat
May 7, 2015 10:33 AM EDTToday's IPO for Collegium Pharmaceutical, Inc., (Nasdaq: COLL) opened for trading at $12 after pricing 5,800,000 shares of its common stock at a price to the public of $12.
Jefferies LLC and Piper Jaffray & Co. are acting as joint book-running managers. Wells Fargo Securities, LLC... More
Collegium Pharma (COLL) Prices 5.8M Common IPO at $12/Share
May 7, 2015 7:46 AM EDTCollegium Pharmaceutical, Inc., (Nasdaq: COLL) today announced the pricing of its initial public offering of 5,800,000 shares of its common stock at a price to the public of $12.00 per share, before underwriting discounts and commissions. All of the shares in the offering are being sold... More
